Health Library
Burkitt lymphoma
B-cell lymphoma; High-grade B-cell lymphoma; Small noncleaved cell lymphoma; Burkitt's lymphoma
Burkitt lymphoma (BL) is a very fast growing form of non-Hodgkin lymphoma.
Images
I Would Like to Learn About:
Causes
BL was first discovered in children in certain parts of Africa. It also occurs in the United States.
The African type of BL is closely associated with the Epstein-Barr virus (EBV), the main cause of infectious mononucleosis. The North American form of BL is not commonly linked to EBV.
People with HIV/AIDS have an increased risk for this condition. BL is most often seen in males.
Symptoms
BL may first be noticed as a swelling of the lymph nodes (glands) in the head and neck. These swollen lymph nodes are often painless, but can grow very rapidly.
In the types commonly seen in the United States, the cancer often starts in the belly area (abdomen). The disease can also start in the ovaries, testes, brain, kidneys, liver, and spinal fluid.
Other general symptoms may include:
- Fever
- Night sweats
- Unexplained weight loss
Exams and Tests
The health care provider will perform a physical exam. Tests that may be done include:
- Bone marrow biopsy
- Chest x-ray
- CT scan of the chest, abdomen, and pelvis
- Complete blood count (CBC)
- Examination of the spinal fluid
- Lymph node biopsy
- PET scan
Treatment
Chemotherapy is used to treat this type of cancer. If the cancer does not respond to chemotherapy alone, a bone marrow transplant may be done.
Outlook (Prognosis)
More than one half of people with BL can be cured with intensive chemotherapy. The cure rate may be lower if the cancer spreads to the bone marrow or spinal fluid. The outlook is poor if the cancer comes back after a remission or does not go into remission as a result of the first cycle of chemotherapy.
Possible Complications
Possible complications of BL include:
- Complications of treatment
- Spread of the cancer
When to Contact a Medical Professional
Call your provider if you have symptoms of BL.
Related Information
Hodgkin lymphomaMononucleosis
Tumor
Radiation therapy
References
Lewis R, Plowman PN, Shamash J. Malignant disease. In: Feather A, Randall D, Waterhouse M, eds. Kumar and Clarke's Clinical Medicine. 10th ed. Philadelphia, PA: Elsevier; 2021:chap 6.
National Cancer Institute website. Adult non-Hodgkin lymphoma treatment (PDQ) - health professional version. www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq#section/all. Updated January 18, 2022. Accessed June 29, 2022.
Said JW. Immunodeficiency-related lymphoproliferative disorders. In: Jaffe ES, Arber DA, Campo E, Harris NL, Quintanilla-Martinez L, eds. Hematopathology. 3rd ed. Philadelphia, PA: Elsevier; 2018:chap 10.
BACK TO TOPReview Date: 4/29/2022
Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here. |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.